Share Your Research, Maximize Your Social Impacts
Apixaban Anticoagulation Failure in Patients with Bio-Prosthetic Aortic Valve with Concomitant Paroxysmal Atrial Fibrillation Presenting as LAD Thrombosis, A Case Report
Journal: International Journal of Science and Research (IJSR) (Vol.3, No. 5)Publication Date: 2014-05-15
Authors : Umar Hayat; Wajih Ullah; Abdur Rehman; Muhammad Yousaf;
Page : 739-742
Keywords : NOACs New oral Anticoagulants; TE Thromboembolic events; LAD Left anterior descending coronary artery; EKG Electrocardiogram; CAT Scan Computerized tomography; PT Prothrombin time; aPPT activated partial thromboplastin time; INR International normalized r;
Source : Download
Find it from : Google Scholar
Abstract
One of the significant risk factor for development of a thromboembolic events in patients with bio-prosthetic aortic valve is co-occurence of paroxysmal atrial fibrillation. Coumadin and New Oral Anti-Coagulants (NOACs) have been used for prevention of these events. Recent studies have shown that NOACs are less potent in preventing these thromboembolic events like stroke and myocardial infarction etc. compared to Coumadin.
Other Latest Articles
- Exploring the Efficiency of ICT Service Delivery and Identifying Critical Factors for Improvement in Bhutan
- Research on Credit Risk Assessment of Sci - tech Enterprises Based on Logistic Model
- Occupational Accidents in Construction Works - Causes and Suggestions for Prevention
- An Evaluation of Head Teacher Leadership in Lusaka District of Zambia: Preliminary Findings
- Does Global Human Resource Practice Affect Employee Job Satisfaction In Palestinian Firms? An Evidence?Based Analytical
Last modified: 2021-06-30 19:59:36